Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 210 | 2 | 231 | +23 |
| Shares | 157.8M | 1.26M | 156.9M | +348.7K (+0.2%) |
| Value | $6.67B | $53.1M | $6.42B | −$201.1M (−3.0%) |
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (43)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (20)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Voloridge Investment Management, LLC | 564,044 | $23.8M |
| Rock Springs Capital Management LP | 547,946 | $23.2M |
| Capital International Investors | 253,495 | $10.7M |
| Alps Advisors Inc | 128,068 | $5.41M |
| American International Group, Inc. | 35,294 | $1.49M |
| Mirae Asset Global Investments Co., Ltd. | 31,526 | $875.6K |
| Two Sigma Investments, LP | 19,700 | $832.7K |
| DLD Asset Management, LP | 16,500 | $697.5K |
| Black Maple Capital Management LP | 15,702 | $663.7K |
| Teza Capital Management LLC | 13,507 | $570.9K |
| Greenland Capital Management LP | 8,960 | $378.7K |
| Oxford Asset Management LLP | 8,354 | $353.1K |
| Ameritas Investment Partners, Inc. | 7,236 | $305.9K |
| Prudential Financial Inc | 5,099 | $215.5K |
| Belvedere Trading LLC | 5,001 | $211.4K |
| Metropolitan Life Insurance Co | 3,833 | $162.0K |
| Quest Partners LLC | 423 | $17.9K |
| First Manhattan Co | 100 | $4.23K |
| Elequin Capital LP | 99 | $4.18K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13 | $549 |
Not filed for Q2 2024 yet (2)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Segantii Capital Management Ltd | 1,143,426 | $48.3M |
| Credit Suisse AG | 111,634 | $4.72M |